Ms Gillian Stynes
Uxbridge (United Kingdom of Great Britain & Northern Ireland)
Differences in the characteristics of patients with non-valvular atrial fibrillation who are newly prescribed apixaban, rivaroxaban, dabigatran and VKA in general practice in the UK
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Anticoagulation in atrial fibrillation
Is there a difference in treatment persistence across oral anticoagulants? Results of a UK cohort study evaluating oral anticoagulation therapy in an atrial fibrillation population
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Anticoagulation in atrial fibrillation
ESC 365 is supported by
